AtriCure, Inc. Investing Cash Flow
AtriCure, Inc. (ATRC) reported Investing Cash Flow of -$7.62 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-27.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-07-27
- AtriCure, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$3.77M.
- AtriCure, Inc. net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$3.85M.
- AtriCure, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$2.60M.
- AtriCure, Inc. net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was -$2.60M, a 159.31% decline year-over-year.
- AtriCure, Inc. net cash provided by (used in) investing activities for fiscal 2025 was -$14.55M, a 148.12% decline from fiscal 2024.
- AtriCure, Inc. net cash provided by (used in) investing activities for fiscal 2024 was $30.23M, a 38.58% increase from fiscal 2023.
- AtriCure, Inc. net cash provided by (used in) investing activities for fiscal 2023 was $21.82M, a 50.42% decline from fiscal 2022.
- AtriCure, Inc. net cash provided by (used in) investing activities for fiscal 2022 was $44.01M, a 87.23% increase from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 3 month as first filed | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 6 month as first filed | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 9 month as first filed | Net Cash Provided by (Used in) Investing Activities 12 month | Net Cash Provided by (Used in) Investing Activities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-27 | -$7.62M 10-Q · filed 2026-07-27 | -$10.22M derived: sum of 3 quarters · filed 2026-07-27 | -$12.82M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2026-03-31 | -$3.85M 10-Q · filed 2026-05-06 | -$6.45M derived: sum of 2 quarters · filed 2026-05-06 | -$9.06M derived: sum of 3 quarters · filed 2026-05-06 | -$16.72M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2025-12-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$5.21M derived: sum of 2 quarters · filed 2026-02-19 | -$12.87M derived: sum of 3 quarters · filed 2026-07-27 | -$14.55M 10-K · filed 2026-02-19 | ||||
| 2025-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | -$10.27M derived: sum of 2 quarters · filed 2026-07-27 | -$11.95M 10-Q · filed 2025-10-30 | -$26.64M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2025-06-30 | -$7.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-27 | -$9.34M 10-Q · filed 2026-07-27 | -$24.04M derived: sum of 3 quarters · filed 2026-07-27 | -$19.64M derived: sum of 4 quarters · filed 2026-07-27 | ||||
| 2025-03-31 | -$1.68M 10-Q · filed 2026-05-06 | -$16.37M derived: sum of 2 quarters · filed 2026-05-06 | -$11.98M derived: sum of 3 quarters · filed 2026-05-06 | $18.91M derived: sum of 4 quarters · filed 2026-05-06 | ||||
| 2024-12-31 | -$14.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | -$10.30M derived: sum of 2 quarters · filed 2026-02-19 | $20.59M derived: sum of 3 quarters · filed 2026-02-19 | $30.23M 10-K · filed 2026-02-19 | ||||
| 2024-09-30 | $4.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $35.28M derived: sum of 2 quarters · filed 2025-10-30 | $44.93M 10-Q · filed 2025-10-30 | $42.14M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-06-30 | $30.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30 | $40.53M 10-Q · filed 2025-07-30 | $37.75M derived: sum of 3 quarters · filed 2026-02-19 | $49.62M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2024-03-31 | $9.64M 10-Q · filed 2025-04-30 | $6.86M derived: sum of 2 quarters · filed 2026-02-19 | $18.73M derived: sum of 3 quarters · filed 2026-02-19 | $2.65M derived: sum of 4 quarters · filed 2026-02-19 | ||||
| 2023-12-31 | -$2.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | $9.08M derived: sum of 2 quarters · filed 2026-02-19 | -$7.00M derived: sum of 3 quarters · filed 2026-02-19 | $21.82M 10-K · filed 2026-02-19 | ||||
| 2023-09-30 | $11.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$4.21M derived: sum of 2 quarters · filed 2024-10-30 | $24.60M 10-Q · filed 2024-10-30 | $31.61M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-06-30 | -$16.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-31 | $12.73M 10-Q · filed 2024-07-31 | $19.73M derived: sum of 3 quarters · filed 2025-02-14 | $16.50M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2023-03-31 | $28.81M 10-Q · filed 2024-05-02 | $35.81M derived: sum of 2 quarters · filed 2025-02-14 | $32.58M derived: sum of 3 quarters · filed 2025-02-14 | $53.10M derived: sum of 4 quarters · filed 2025-02-14 | ||||
| 2022-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-14 | $3.76M derived: sum of 2 quarters · filed 2025-02-14 | $24.28M derived: sum of 3 quarters · filed 2025-02-14 | $44.01M 10-K · filed 2025-02-14 | ||||
| 2022-09-30 | -$3.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $17.28M derived: sum of 2 quarters · filed 2023-11-02 | $37.00M 10-Q · filed 2023-11-02 | $38.08M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-06-30 | $20.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $40.24M 10-Q · filed 2023-07-26 | $41.32M derived: sum of 3 quarters · filed 2024-02-16 | $16.22M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2022-03-31 | $19.72M 10-Q · filed 2023-05-03 | $20.80M derived: sum of 2 quarters · filed 2024-02-16 | -$4.30M derived: sum of 3 quarters · filed 2024-02-16 | -$20.36M derived: sum of 4 quarters · filed 2024-02-16 | ||||
| 2021-12-31 | $1.08M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-16 | -$24.02M derived: sum of 2 quarters · filed 2024-02-16 | -$40.08M derived: sum of 3 quarters · filed 2024-02-16 | $23.50M 10-K · filed 2024-02-16 | ||||
| 2021-09-30 | -$25.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$41.16M derived: sum of 2 quarters · filed 2022-11-02 | $22.43M 10-Q · filed 2022-11-02 | $20.45M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$16.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $47.53M 10-Q · filed 2022-08-03 | $45.55M derived: sum of 3 quarters · filed 2023-02-22 | -$13.19M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | $63.59M 10-Q · filed 2022-05-04 | $61.61M derived: sum of 2 quarters · filed 2023-02-22 | $2.87M derived: sum of 3 quarters · filed 2023-02-22 | -$109.94M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$1.98M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$60.72M derived: sum of 2 quarters · filed 2023-02-22 | -$173.53M derived: sum of 3 quarters · filed 2023-02-22 | -$156.20M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$58.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$171.55M derived: sum of 2 quarters · filed 2021-11-04 | -$154.22M 10-Q · filed 2021-11-04 | -$156.82M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-06-30 | -$112.81M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$95.48M 10-Q · filed 2021-08-05 | -$98.08M derived: sum of 3 quarters · filed 2022-02-17 | -$107.72M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2020-03-31 | $17.33M 10-Q · filed 2021-04-28 | $14.73M derived: sum of 2 quarters · filed 2022-02-17 | $5.10M derived: sum of 3 quarters · filed 2022-02-17 | $4.17M derived: sum of 4 quarters · filed 2022-02-17 | ||||
| 2019-12-31 | -$2.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-17 | -$12.23M derived: sum of 2 quarters · filed 2022-02-17 | -$13.16M derived: sum of 3 quarters · filed 2022-02-17 | -$2.15M 10-K · filed 2022-02-17 | ||||
| 2019-09-30 | -$9.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | -$10.56M derived: sum of 2 quarters · filed 2020-11-06 | $454.00K 10-Q · filed 2020-11-06 | -$70.37M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-06-30 | -$930.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | $10.09M 10-Q · filed 2020-07-29 | -$60.74M derived: sum of 3 quarters · filed 2021-02-26 | -$61.34M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2019-03-31 | $11.02M 10-Q · filed 2020-04-30 | -$59.81M derived: sum of 2 quarters · filed 2021-02-26 | -$60.41M derived: sum of 3 quarters · filed 2021-02-26 | -$70.14M derived: sum of 4 quarters · filed 2021-02-26 | ||||
| 2018-12-31 | -$70.83M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$71.43M derived: sum of 2 quarters · filed 2021-02-26 | -$81.16M derived: sum of 3 quarters · filed 2021-02-26 | -$85.40M 10-K · filed 2021-02-26 | ||||
| 2018-09-30 | -$601.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$10.33M derived: sum of 2 quarters · filed 2019-10-31 | -$14.58M 10-Q · filed 2019-10-31 | -$13.51M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | -$9.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | -$13.98M 10-Q · filed 2019-07-31 | -$12.91M derived: sum of 3 quarters · filed 2020-02-24 | -$15.51M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-03-31 | -$4.25M 10-Q · filed 2019-04-26 | -$3.18M derived: sum of 2 quarters · filed 2020-02-24 | -$5.78M derived: sum of 3 quarters · filed 2020-02-24 | -$6.21M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | -$1.53M derived: sum of 2 quarters · filed 2020-02-24 | -$1.97M derived: sum of 3 quarters · filed 2020-02-24 | $3.76M 10-K · filed 2020-02-24 | ||||
| 2017-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | -$3.03M derived: sum of 2 quarters · filed 2018-11-02 | $2.70M 10-Q · filed 2018-11-02 | |||||
| 2017-06-30 | -$431.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $5.29M 10-Q · filed 2018-08-02 | ||||||
| 2017-03-31 | $5.73M 10-Q · filed 2018-04-27 | |||||||
| 2016-12-31 | -$12.08M 10-K · filed 2019-03-01 | |||||||
| 2015-12-31 | -$10.50M 10-K · filed 2018-02-28 | |||||||
| 2013-12-31 | -$7.94M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | -$13.32M derived: sum of 2 quarters · filed 2014-03-11 | -$12.70M derived: sum of 3 quarters · filed 2014-03-11 | -$14.15M 10-K · filed 2014-03-11 | ||||
| 2013-09-30 | -$5.38M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$4.76M derived: sum of 2 quarters · filed 2013-11-01 | -$6.21M 10-Q · filed 2013-11-01 | -$6.22M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2013-06-30 | $614.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$835.00K 10-Q · filed 2013-08-02 | -$846.00K derived: sum of 3 quarters · filed 2014-03-11 | -$369.00K derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2013-03-31 | -$1.45M 10-Q · filed 2013-05-03 | -$1.46M derived: sum of 2 quarters · filed 2014-03-11 | -$983.00K derived: sum of 3 quarters · filed 2014-03-11 | -$3.55M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-12-31 | -$11.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $466.00K derived: sum of 2 quarters · filed 2014-03-11 | -$2.10M derived: sum of 3 quarters · filed 2014-03-11 | -$2.80M 10-K · filed 2014-03-11 | ||||
| 2012-09-30 | $477.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-01 | -$2.09M derived: sum of 2 quarters · filed 2013-11-01 | -$2.79M 10-Q · filed 2013-11-01 | $4.15M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-06-30 | -$2.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-02 | -$3.26M 10-Q · filed 2013-08-02 | $3.67M derived: sum of 3 quarters · filed 2014-03-11 | $3.98M derived: sum of 4 quarters · filed 2014-03-11 | ||||
| 2012-03-31 | -$697.00K 10-Q · filed 2013-05-03 | -$697.17K 10-Q · filed 2012-05-04 | $6.24M derived: sum of 2 quarters · filed 2014-03-11 | $6.54M derived: sum of 3 quarters · filed 2014-03-11 | $1.96M derived: sum of 4 quarters · filed 2014-03-11 | |||
| 2011-12-31 | $6.93M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $7.24M derived: sum of 2 quarters · filed 2014-03-11 | $2.65M derived: sum of 3 quarters · filed 2014-03-11 | $2.72M 10-K · filed 2014-03-11 | $2.72M 10-K · filed 2012-03-12 | |||
| 2011-09-30 | $306.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | -$4.28M derived: sum of 2 quarters · filed 2012-11-02 | -$4.21M 10-Q · filed 2012-11-02 | -$4.21M 10-Q · filed 2011-11-04 | -$4.89M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-06-30 | -$4.58M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -$4.51M 10-Q · filed 2012-08-03 | -$4.51M 10-Q · filed 2011-08-05 | -$5.20M derived: sum of 3 quarters · filed 2013-03-08 | -$8.50M derived: sum of 4 quarters · filed 2013-03-08 | |||
| 2011-03-31 | $69.40K 10-Q · filed 2012-05-04 | -$616.19K derived: sum of 2 quarters · filed 2013-03-08 | -$3.92M derived: sum of 3 quarters · filed 2013-03-08 | |||||
| 2010-12-31 | -$685.59K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | -$3.99M derived: sum of 2 quarters · filed 2013-03-08 | -$3.33M 10-K · filed 2013-03-08 | -$3.33M 10-K · filed 2012-03-12 | ||||
| 2010-09-30 | -$3.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | -$2.65M 10-Q · filed 2011-11-04 | ||||||
| 2010-06-30 | $652.71K 10-Q · filed 2011-08-05 | |||||||
| 2009-12-31 | -$2.17M 10-K · filed 2012-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |